Pasar al contenido principal

DISECCION GENETICA DE LA PRECISION TRANSCRIPCIONAL CONTROLADA POR POTENCIADORES

PID2021-123030NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

POSTRE: A tool to predict the pathological effects of human structural variants

  • Sánchez-Gaya, Víctor
  • Rada-Iglesias, Álvaro
Understanding the pathological impact of non-coding genetic variation is a major challenge in medical genetics. Accumulating evidences indicate that a significant fraction of genetic alterations, including structural variants (SVs), can cause human disease by altering the function of non-coding regulatory elements, such as enhancers. In the case of SVs, described pathomechanisms include changes in enhancer dosage and long-range enhancer-gene communication. However, there is still a clear gap between the need to predict and interpret the medical impact of non-coding variants, and the existence of tools to properly perform these tasks. To reduce this gap, we have developed POSTRE (Prediction Of STRuctural variant Effects), a computational tool to predict the pathogenicity of SVs implicated in a broad range of human congenital disorders. By considering disease-relevant cellular contexts, POSTRE identifies SVs with either coding or long-range pathological consequences with high specificity and sensitivity. Furthermore, POSTRE not only identifies pathogenic SVs, but also predicts the disease-causative genes and the underlying pathological mechanism (e.g, gene deletion, enhancer disconnection, enhancer adoption, etc.)., Víctor Sánchez-Gaya is supported by a doctoral fellowship from the University of Cantabria (Spain); Work in the Rada-Iglesias laboratory is supported by the EMBO Young Investigator Programme [PGC2018-095301-B-I00, PID2021-123030NB-I00] funded by MCIN/AEI/10.13039/501 100 011 033 and by ‘ERDF A way of making Europe’ [RED2018-102553-T (REDEVNEURAL 3.0)] funded by MCIN/AEI/10.13039/501 100 011 033; ERC CoG ‘PoisedLogic’ [862 022] funded by the European Research Council and grant ‘ENHPATHY’ H2020-MSCA-ITN-2019-860002 funded by the European Commission.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The interaction between enhancer variants and environmental factors as an overlooked aetiological paradigm in human complex disease

  • Robert, Sarah
  • Rada-Iglesias, Álvaro
The interactions between genetic and environmental risk factors contribute to the aetiology of complex human diseases. Genome-wide association studies (GWAS) have revealed that most of the genetic variants associated with complex diseases are located in the non-coding part of the genome, preferentially within enhancers. Enhancers are distal cis-regulatory elements composed of clusters of transcription factors binding sites that positively regulate the expression of their target genes. The generation of genome-wide maps for histone marks (e.g., H3K27ac), chromatin accessibility and transcription factor and coactivator (e.g., p300) binding profiles have enabled the identification of enhancers across many human cell types and tissues. Nonetheless, the functional and pathological consequences of the majority of disease-associated genetic variants located within enhancers seem to be rather minor under normal conditions, thus questioning their medical relevance. Here we propose that, due to the prevalence of enhancer redundancy, the pathological effects of many disease-associated non-coding genetic variants might be preferentially (or even only) manifested under environmental stress., Sarah Robert is supported by ‘ENHPATHY’ H2020-MSCA-ITN-2019-860002. Work in the Rada-Iglesias laboratory is supported by grants PID2021-123030NB-I00 funded by MCIN/AEI/10.13039/501100011033, grant ERC CoG ‘PoisedLogic’ (862022) funded by the European Research Council and grant ‘ENHPATHY’ H2020-MSCA-ITN-2019-860002 funded by the European Commission., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cooperative insulation of regulatory domains by CTCF-dependent physical insulation and promoter competition

  • Ealo, Thais
  • Sanchez-Gaya, Victor
  • Respuela, Patricia
  • Muñoz-San Martín, María
  • Martin-Batista, Elva
  • Haro, Endika
  • Rada-Iglesias, Álvaro
The specificity of gene expression during development requires the insulation of regulatory domains to avoid inappropriate enhancer-gene interactions. In vertebrates, this insulator function is mostly attributed to clusters of CTCF sites located at topologically associating domain (TAD) boundaries. However, TAD boundaries allow some physical crosstalk across regulatory domains, which is at odds with the specific and precise expression of developmental genes. Here we show that developmental genes and nearby clusters of CTCF sites cooperatively foster the robust insulation of regulatory domains. By genetically dissecting a couple of representative loci in mouse embryonic stem cells, we show that CTCF sites prevent undesirable enhancer-gene contacts (i.e. physical insulation), while developmental genes preferentially contribute to regulatory insulation through non-structural mechanisms involving promoter competition rather than enhancer blocking. Overall, our work provides important insights into the insulation of regulatory domains, which in turn might help interpreting the pathological consequences of certain structural variants., Work in the Rada-Iglesias laboratory is supported by grant PID2021-123030NB-I00 (AR-I) funded by MCIN/AEI/ 10.13039/501100011033 and by ERDF A way of making Europe, grant RED2022-134100-T (AR-I) (REDEVNEURAL 3.0) funded by MCIN/AEI /10.13039/501100011033, grant ERC CoG PoisedLogic (862022) (A.R.-I.) funded by the European Research Council, grant ENHPATHY H2020-MSCA-ITN-2019-860002 (A.R.-I.) funded by the European Commission, grant Chrom_rare HORIZON-MSCA-2021-DN-01-101073334 (A.R.-I.) funded by the European Commission. E.M.B was granted with a fellowship from the network PIE-202120E047-Conexiones-Life